long intergenic non-protein coding RNA 1749Genealiases: []
Q-omics provides the consensus-scored LINC01749 profile across patient tissues and cancer cell-line models. LINC01749 expression is associated with patient survival in 19 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, LINC01749 is differentially expressed in 7, with the highest sampling consensus in COAD. Additionally, LINC01749 RNA expression shows 10,343 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight ACC, COAD, and THYM as cancer lineages where LINC01749 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01749 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01749 survival associations across molecular data types. LINC01749 RNA expression shows survival associations in the most cancer types (19). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01749 RNA expression–survival associations across cancer types. High LINC01749 expression shows unfavorable associations in ACC, LIHC and KICH, but favorable associations in HNSC, SKCM and THYM. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for LINC01749 RNA expression.
This table summarizes LINC01749 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 7. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01749. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01749 shows lower tumor expression in KIRC and higher tumor expression in COAD, HNSC, LUSC, LUAD and CHOL. The COAD box plot shows higher LINC01749 RNA expression in tumor versus normal tissue (log2 FC = +0.062, t-test p = .010).
This table shows molecular features associated with LINC01749 in patient tissues and cancer cell lines. In patient samples, LINC01749 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
